High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: First results of a randomized trial

Author： Verrill Mark  

Publisher： Informa Healthcare

ISSN： 1473-3404

Source： The Women's Oncology Review, Vol.5, Iss.1, 2005-03, pp. : 41-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Health-Related Quality of Life in Multiple Myeloma Patients Receiving High-Dose Chemotherapy with Autologous Blood Stem-Cell Support

By Gulbrandsen N.   Wisløff F.   Brinch L.   Carlson K.   Dahl I.M.   Gimsing P.   Hippe E.   Hjorth M.   Knudsen L.M.   Lamvik J.   Lenhoff S.   Løfvenberg E.   Nesthus I.   Lanng Nielsen J.   Turesson I.   Westin J.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 65-77

Humana Press, Inc

Access to resources Recommend Favorite

Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer

By Ikeba Kazunori   Okubo Mitsuo   Takeda Satoru   Kinoshita Katsuyuki   Maeda Hiroo  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 113-119

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support

By Kollmannsberger C.   Schleucher N.   Rick O.   Metzner B.   Hartmann J.T.   Schoffski P.   Beyer J.   Casper J.   Sosada M.   Schmoll H.-J.   Bohlke I.   Meisner C.   Kanz L.   Bokemeyer C.  

European Journal of Cancer, Vol. 39, Iss. 6, 2003-04 ,pp. : 775-782

Elsevier

Access to resources Recommend Favorite

Very High-dose Chemotherapy with Autologous Peripheral Stem Cell Support in Advanced Ovarian Cancer

By Benedetti-Panici P.   Greggi S.   Scambia G.   Salerno M.G.   Baiocchi G.   Laurelli G.   Menichella G.   Pierelli L.   Foddai M.L.   Serafini R.   Bizzi B.   Mancuso S.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 1987-1992

Elsevier

Access to resources Recommend Favorite

Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: Is tailored and dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than marrow-supported high-dose chemotherapy - results from a randomized study

By Kellokumpu-Lehtinen P.   Bergh J.   Salminen E.   Wiklund T.   Lehtinen S.   Aronen P.   Sintonen H.  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 146-152

Informa Healthcare

Access to resources Recommend Favorite